How to map SF-12 scores to EQ-5D utilities with regression for cost-utility analysis, and the accuracy of mapping methods.

How WHO-CHOICE estimates programme support costs for disease control, and why costs beyond service delivery matter.

A critical review of the health methodology behind the 1993 World Development Report, including DALYs and cost-effectiveness.

How to develop discrete choice experiments to study digital health uptake: design steps and methodological considerations.

The current costs and future projections of osteoporosis in Florida, and what an ageing population means for the burden.

Methods and findings from the PRET and PRET-AS projects on valuing health states for economic evaluation.

Constructive technology assessment in health care: how to shape new technologies early through stakeholder dialogue.

Strategies for measuring health-state preferences: standard gamble, time trade-off, rating scales and their trade-offs.

How costs of illness should be handled in cost-effectiveness analysis: a review of the methodological debate.

Practical tools from EUnetHTA for health technology assessment in Europe, including the HTA Core Model.

Scaling methods for measuring health-state preferences: rating scales and other techniques, from Froberg and Kane.

A review of discrete choice experiments in health economics: design trends, applications and methodological issues.

Direct costs of an intensive care unit stay in four European countries, and how a standardised costing methodology makes ICU costs comparable.

A systematic review of the methods used to estimate direct costs in US cost-of-illness studies, and why they vary.

Time trade-off in health valuation: how TTO methods vary across studies, why it matters for QALYs, and Attema et al.’s call for standardisation.

How QALYs are calculated in trial-based cost-utility analyses: a review of 23 studies showing inconsistent methods and poor transparency.